• NB-110 is a novel ophthalmic formulation comprising a synthetic cannabinoid Nabilone in the absence of any preservative. The formulation mimicking human tear enables efficacious delivery through cornea to retina and optical nerves in the back of eye.
• Nabilone is a CB1/CB2 receptor agonist. Nabilone is crystalline and stable under heat, light and oxygen, an advantage over other cannabinoids (dronabinol, cannabidiol).
• NB-110 lowers interocular pressure of glaucoma patients and could protect optical nerves.

The combination makes this drug unique and differentiates from marketed glaucoma medications.